Kontafarma China Holdings Ltd (HK:1312) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kontafarma China Holdings Ltd has announced changes to its board of directors effective 7 June 2024, revealing a new composition of executive and non-executive members, including Wang Feifei as Chairman and President. The company has also detailed the structure of its seven board committees, specifying the roles of each director across these committees, with clear designations for chairpersons and members.
For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.